SHIFT AI Newsroom · GLOBAL
Trial Launched for Injectable Cagrilintide in People With Excess Body Weight
A new clinical trial is comparing two versions of injectable Cagrilintide with a placebo in individuals with excess body weight.
A new clinical trial, A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight, has been registered on ClinicalTrials.gov. The trial aims to compare the efficacy of two different versions of injectable Cagrilintide with a placebo in individuals with excess body weight.
What this means in the UK
This trial may potentially lead to new treatment options for people in the UK with excess body weight, but its impact and availability in the UK are currently unknown.
Known facts
- A research study is comparing two different versions of injectable Cagrilintide and a placebo in people with excess body weight.